Panacea Biotech stock soars after collaboration with Bionpharma

DSIJ Intelligence / 28 Jul 2017

Panacea Biotech stock soars after collaboration with Bionpharma

After announcing a joint collaboration with Bionpharma, Panacea Biotech gained 5.56% at Rs 142.35 per share on the BSE on Friday.

After announcing a joint collaboration with Bionpharma, Panacea Biotech gained 5.56% at Rs 142.35 per share on the BSE on Friday.
 
The company has collaborated with Bionpharma for development, license, manufacturing, supply and sales of seven complex generic pharmaceutical products which are currently under development and represent a total market potential of more than 800 million.
 
Panacea Biotech will be responsible for development, filing, registration manufacturing and supply of these ANDAs while Bionpharma will be responsible for importation, warehousing, sales and distribution of these ANDAs in the US and its territories.
 
Under the previous arrangement, Bionpharma is also an exclusive distributor for two ANDAs of Panacea Biotech for the US market.

If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.